PlushCare delivers virtual primary care, clinically based weight management and mental health services in all 50 states, emphasizing long-term doctor–patient relationships and evidence-based care across 6,800-plus conditions. Its clinical weight program combines personalized coaching, labs and, when appropriate, FDA-approved medications such as GLP-1s, with ongoing check-ins and monitoring to sustain results and reduce regain. In 2020, PlushCare joined Accolade in a $450 million transaction to create Accolade Care, and in 2024 the company began accepting Medicare Part B to expand access for 64-plus million beneficiaries by removing transportation barriers and shortening wait times. In 2025 Accolade’s acquisition by Transcarent extended the platform’s reach to a combined audience of roughly 20 million people.
